TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,305,000 Value ($000) $1,856 Avg Close — Range —
Q3 2025
Shares 1,305,000 Value ($000) $1,471 Avg Close — Range —
Q4 2024
Shares 3,000,000 Value ($000) $2,857 Avg Close — Range —
Q3 2024
Shares 3,000,000 Value ($000) $2,577 Avg Close — Range —
Q1 2024
Shares 2,616,000 Value ($000) $1,647 Avg Close — Range —
Q4 2023
Shares 3,121,000 Value ($000) $1,994 Avg Close — Range —
Q3 2023
Shares 3,121,000 Value ($000) $2,001 Avg Close — Range —
Q2 2023
Shares 1,621,000 Value ($000) $1,305 Avg Close — Range —